Search
for
Sort by
Research 271–300 of 1000+
- NG2 Proteoglycan Expression in Mouse Skin: Altered Postnatal Skin Development in the NG2 Null Mouse
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation
- Dermatologic care of patients with differences of sex development
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- Maternal Melatonin Contributes to Offspring Hair Follicle Development Through Transcriptional Regulation of the AP-1 Complex and MAPK Pathway
- Progress on mitochondria and hair follicle development in androgenetic alopecia: relationships and therapeutic perspectives
- Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments
- The potential impact of melanosomal pH and metabolism on melanoma
- Dynamic Transcriptome Profile Analysis of Mechanisms Related to Melanin Deposition in Chicken Muscle Development
- DNA Methylation as an Epigenetic Memory Keeper during Skin Development and Regeneration
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Amino acid–derived defense metabolites from plants: A potential source to facilitate novel antimicrobial development
- Systematic analysis of somatic mutations driving cancer: uncovering functional protein regions in disease development
- RSPO1-mutated keratinocytes from palmoplantar keratoderma display impaired differentiation, alteration of cell–cell adhesion, EMT-like phenotype and invasiveness properties: implications for squamous cell carcinoma susceptibility in patients with 46XX disorder of sexual development
- Lipidomics Combined with Network Pharmacology to Explore Differences in the Mechanisms of Grey Hair Development Between Type 2 Diabetes Mellitus and Normal Populations (Female)
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- <i>In-Vitro</i> Effect of Sex Steroids on Mouse Melanoma (B16F10) Cell Growth
- Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- The remarkable legacy of the K6/ODC mouse: mechanisms of polyamine-promoted tumorigenesis revealed
- Abstract 3889: Cyclin-dependent kinase 4 levels affect the number of hair follicle stem cells in mouse epidermis
- Sox9 regulates melanocytic fate decision of adult hair follicle stem cells
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Advances in Nanocarrier Systems for Dermatologic Transdermal Drug Delivery: A Chemical and Molecular Review
- Biocompatible exosomes derived from <i>Pinctada martensii</i> mucus for therapeutic melanin regulation via α-MSH/NF-κB/MITF pathway
- Two novel CreER<sup>T2</sup> transgenic mouse lines to study melanocytic cells in vivo